vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是Ribbon Communications Inc.的2.0倍（$321.1M vs $162.6M），Ribbon Communications Inc.净利率更高（54.8% vs -18.2%，领先73.0%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs -10.3%）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
MDGL vs RBBN — 直观对比
营收规模更大
MDGL
是对方的2.0倍
$162.6M
营收增速更快
MDGL
高出221.1%
-10.3%
净利率更高
RBBN
高出73.0%
-18.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $162.6M |
| 净利润 | $-58.6M | $89.1M |
| 毛利率 | — | 42.9% |
| 营业利润率 | -18.6% | — |
| 净利率 | -18.2% | 54.8% |
| 营收同比 | 210.8% | -10.3% |
| 净利润同比 | 1.4% | — |
| 每股收益（稀释后） | $-2.55 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $321.1M | $227.3M | ||
| Q3 25 | $287.3M | $215.4M | ||
| Q2 25 | $212.8M | $220.6M | ||
| Q1 25 | $137.3M | $181.3M | ||
| Q4 24 | $103.3M | $251.4M | ||
| Q3 24 | $62.2M | $210.2M | ||
| Q2 24 | — | $192.6M |
净利润MDGLRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $-58.6M | — | ||
| Q3 25 | $-114.2M | $-12.1M | ||
| Q2 25 | $-42.3M | $-11.1M | ||
| Q1 25 | $-73.2M | $-26.2M | ||
| Q4 24 | $-59.4M | — | ||
| Q3 24 | $-107.0M | $-13.4M | ||
| Q2 24 | — | $-16.8M |
毛利率MDGLRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 50.1% | ||
| Q2 25 | — | 49.6% | ||
| Q1 25 | 96.7% | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 50.8% |
营业利润率MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | -18.6% | 4.1% | ||
| Q3 25 | -39.7% | 1.3% | ||
| Q2 25 | -22.2% | 1.9% | ||
| Q1 25 | -57.8% | -10.8% | ||
| Q4 24 | -64.8% | 13.2% | ||
| Q3 24 | -187.1% | -0.4% | ||
| Q2 24 | — | -1.0% |
净利率MDGLRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | -18.2% | — | ||
| Q3 25 | -39.8% | -5.6% | ||
| Q2 25 | -19.9% | -5.0% | ||
| Q1 25 | -53.4% | -14.5% | ||
| Q4 24 | -57.5% | — | ||
| Q3 24 | -172.0% | -6.4% | ||
| Q2 24 | — | -8.7% |
每股收益（稀释后）MDGLRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $-2.55 | $0.50 | ||
| Q3 25 | $-5.08 | $-0.07 | ||
| Q2 25 | $-1.90 | $-0.06 | ||
| Q1 25 | $-3.32 | $-0.15 | ||
| Q4 24 | $-2.50 | $0.05 | ||
| Q3 24 | $-4.92 | $-0.08 | ||
| Q2 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $67.6M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $419.1M |
| 总资产 | $1.3B | — |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $198.7M | $96.4M | ||
| Q3 25 | $295.7M | $74.8M | ||
| Q2 25 | $186.2M | $60.5M | ||
| Q1 25 | $183.6M | $71.2M | ||
| Q4 24 | $100.0M | $87.8M | ||
| Q3 24 | $232.7M | $37.2M | ||
| Q2 24 | — | $64.6M |
总债务MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | $339.9M | $342.1M | ||
| Q3 25 | $339.8M | $344.3M | ||
| Q2 25 | $118.4M | $346.5M | ||
| Q1 25 | $118.0M | $347.4M | ||
| Q4 24 | $117.6M | $348.3M | ||
| Q3 24 | $117.1M | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益MDGLRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $602.7M | $449.0M | ||
| Q3 25 | $625.7M | $360.1M | ||
| Q2 25 | $696.0M | $370.4M | ||
| Q1 25 | $710.6M | $381.8M | ||
| Q4 24 | $754.4M | $404.6M | ||
| Q3 24 | $777.2M | $395.5M | ||
| Q2 24 | — | $405.0M |
总资产MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.0B | $1.1B | ||
| Q1 25 | $996.6M | $1.1B | ||
| Q4 24 | $1.0B | $1.2B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | — | $1.1B |
负债/权益比MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | 0.76× | ||
| Q3 25 | 0.54× | 0.96× | ||
| Q2 25 | 0.17× | 0.94× | ||
| Q1 25 | 0.17× | 0.91× | ||
| Q4 24 | 0.16× | 0.86× | ||
| Q3 24 | 0.15× | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | — |
| 自由现金流率自由现金流/营收 | -41.7% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | $-133.5M | $29.2M | ||
| Q3 25 | $79.8M | $26.5M | ||
| Q2 25 | $-47.1M | $-795.0K | ||
| Q1 25 | $-88.9M | $-3.5M | ||
| Q4 24 | $-104.5M | $61.8M | ||
| Q3 24 | $-67.0M | $-14.8M | ||
| Q2 24 | — | $-9.8M |
自由现金流MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | $-133.8M | $27.3M | ||
| Q3 25 | $79.0M | $21.0M | ||
| Q2 25 | — | $-6.5M | ||
| Q1 25 | — | $-15.7M | ||
| Q4 24 | $-104.7M | $53.8M | ||
| Q3 24 | $-67.8M | $-23.7M | ||
| Q2 24 | — | $-12.9M |
自由现金流率MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | -41.7% | 12.0% | ||
| Q3 25 | 27.5% | 9.7% | ||
| Q2 25 | — | -2.9% | ||
| Q1 25 | — | -8.7% | ||
| Q4 24 | -101.3% | 21.4% | ||
| Q3 24 | -109.0% | -11.3% | ||
| Q2 24 | — | -6.7% |
资本支出强度MDGLRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.9% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 0.0% | 6.7% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 1.3% | 4.2% | ||
| Q2 24 | — | 1.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
